Invesco
SRGA

Invesco’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Invesco’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-707
Closed -$46K – 4083
2021
Q1 		$46K Sell
707
-2,152
-75% -$150K ﹤0.01% 3834
2020
Q4 		$188K Buy
2,859
+214
+8% +$14K ﹤0.01% 3544
2020
Q3 		$144K Sell
2,645
-76
-3% -$5.81K ﹤0.01% 3533
2020
Q2 		$259K Sell
2,721
-290
-10% -$21.6K ﹤0.01% 3387
2020
Q1 		$154K Buy
3,011
+2,430
+418% +$254K ﹤0.01% 3476
2019
Q4 		$48K Buy
+581
New +$40.7K ﹤0.01% 3634
2018
Q2 		– Sell
-420
Closed -$58K – 3932
2018
Q1 		$58K Sell
420
-4,133
-91% -$562K ﹤0.01% 3675
2017
Q4 		$560K Buy
4,553
+168
+4% +$23.1K ﹤0.01% 3262
2017
Q3 		$599K Buy
4,385
+167
+4% +$25.2K ﹤0.01% 3247
2017
Q2 		$740K Buy
4,218
+408
+11% +$58K ﹤0.01% 3179
2017
Q1 		$457K Buy
3,810
+1,539
+68% +$160K ﹤0.01% 3374
2016
Q4 		$221K Sell
2,271
-13
-0.6% -$1.19K ﹤0.01% 3544
2016
Q3 		$215K Buy
2,284
+430
+23% +$43.1K ﹤0.01% 3522
2016
Q2 		$200K Sell
1,854
-29
-2% -$3.4K ﹤0.01% 3540
2016
Q1 		$226K Buy
1,883
+44
+2% +$4.62K ﹤0.01% 3530
2015
Q4 		$219K Buy
1,839
+29
+2% +$3.74K ﹤0.01% 3545
2015
Q3 		$308K Sell
1,810
-87
-5% -$16.7K ﹤0.01% 3432
2015
Q2 		$368K Buy
1,897
+38
+2% +$7.05K ﹤0.01% 3501
2015
Q1 		$276K Sell
1,859
-515
-22% -$78.4K ﹤0.01% 3562
2014
Q4 		$370K Buy
2,374
+175
+8% +$25.2K ﹤0.01% 3426
2014
Q3 		$315K Buy
2,199
+92
+4% +$13.3K ﹤0.01% 3484
2014
Q2 		$275K Sell
2,107
-16
-0.8% -$2.03K ﹤0.01% 3576
2014
Q1 		$260K Buy
2,123
+517
+32% +$56K ﹤0.01% 3647
2013
Q4 		$171K Sell
1,606
-1,014
-39% -$98.4K ﹤0.01% 3855
2013
Q3 		$294K Sell
2,620
-7,393
-74% -$839K ﹤0.01% 3615
2013
Q2 		$1.13M Buy
+10,013
New +$1.22M ﹤0.01% 2782

Other funds holding SRGA

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TC
TownSquare Capital Provo, Utah $444M AUM 24.03% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Invesco's SRGA Position: Q2 2021 in Review

Invesco sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2021, closing a stake of 707 shares — an estimated $46K sold.

Invesco first reported a position in SRGA in Q2 2013 and held it in 26 quarters. The position peaked at $1.13M in Q2 2013. 89 funds tracked by Wall St. Rank hold SRGA as of Q2 2021.

  • Invesco reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Invesco sold 707 Surgalign Holdings, Inc. Common Stock shares in Q2 2021, an estimated $46K.
  • Invesco first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 26 quarters.
  • Invesco's Surgalign Holdings, Inc. Common Stock position peaked at $1.13M in Q2 2013.
  • 89 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2021.

Based on Invesco's 13F filing for Q2 2021, filed 17 Aug 2021.